Ignite Creation Date:
2025-12-24 @ 6:50 PM
Ignite Modification Date:
2025-12-29 @ 1:21 PM
Study NCT ID:
NCT02018757
Status:
UNKNOWN
Last Update Posted:
2014-05-28
First Post:
2013-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC
Sponsor:
First Hospital of China Medical University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Carcinoma, Hepatocellular | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Carcinoma, Hepatocellular | View |
| None | primary liver cancer | View |
| None | primary hepatocellular carcinoma | View |
| None | transarterial chemoembolization | View |
| None | Chemoembolization, Therapeutic | View |
| None | arsenic trioxide | View |
| None | arsenous anhydride | View |
| None | diarsenic trioxide | View |
| None | randomized controlled trial | View |
| None | multicenter study | View |
| None | HCC | View |
| None | TACE | View |